Artelo Biosciences, Inc. (NASDAQ: ARTL) reported Q1 EPS of ($0.78), $0.13 better than the analyst estimate of ($0.91).

For earnings history and earnings-related data on Artelo Biosciences, Inc. (ARTL) click here.